We observed high expression of NFKB2, RELB, pSTAT3, and positive CA9 expression in 30% (26/88), 26% (24/91), 63% (46/73), and 51% (37/72) of the meningioma cases, respectively (Table 4). Here, CA9 is linked to meningioma.